Green bioethics, patient autonomy and informed consent in healthcare
Green bioethics, patient autonomy and informed consent in healthcare
复制标题
医疗保健领域的绿色生物伦理、患者自主权和知情同意
DOI：
--
复制
发表时间：
2023
影响因子：
4.1
通讯作者：
Jonathan Pugh
中科院分区：
文献类型：
--
作者：
David B. Resnik;Jonathan Pugh
绿色生物伦理学是一个研究和学术领域，研究医疗实践和政策对环境的影响，并强调环境价值，如生态可持续性和管理。一些绿色生物伦理学家认为，医疗保健提供者应该告知患者治疗对环境的影响，并倡导将不利影响降至最低的选择。虽然在患者明确表达了对环境的关切的情况下，披露有关治疗对环境影响的信息可以促进自主决策，加强患者与提供者的关系，但在其他情况下，如果让患者感到他们被评判或操纵，可能会产生相反的效果。因此，我们认为，没有一个概括的责任，披露环境影响信息的所有患者在同意过程中。实践绿色生物伦理的提供者应专注于倡导医疗保健融资，组织和交付的系统级变革，并在与患者接触时提出环境问题时使用自由裁量权。
Green bioethics is an area of research and scholarship that examines the impact of healthcare practices and policies on the environment and emphasises environmental values, such as ecological sustainability and stewardship. Some green bioethicists have argued that healthcare providers should inform patients about the environmental impacts of treatments and advocate for options that minimise adverse impacts. While disclosure of information pertaining to the environmental impacts of treatments could facilitate autonomous decision-making and strengthen the patient–provider relationship in situations where patients have clearly expressed environmental concerns, it may have the opposite effect in other situations if makes patients feel like they are being judged or manipulated. We argue, therefore, that there is not a generalisable duty to disclose environmental impact information to all patients during the consent process. Providers who practice green bioethics should focus on advocating for system-level changes in healthcare financing, organisation and delivery and use discretion when bringing up environmental concerns in their encounters with patients.